PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada; Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.\', \'Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.\', \'Bioinformatics, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.\', \'Viral Diseases, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.\', \'Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada.\', \'Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada. Electronic address: heidi.wood@canada.ca.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0732-8893(20)30671-410.1016/j.diagmicrobio.2020.115294
?:doi
?:hasPublicationType
?:journal
  • Diagnostic microbiology and infectious disease
is ?:pmid of
?:pmid
?:pmid
  • 33387896
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.157
?:rankingScore_hIndex
  • 86
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all